Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations - Trial NCT06030011

Timeline & Enrollment

Primary Outcome

Head and neck cancer (HNC) symptoms as assessed by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires (QLQ)

Summary

The PI and the research team developed the New York University (NYU) Electronic Patient Visit
 Assessment (ePVA) for head and neck cancer (HNC) as a patient-reported outcome measure (PRO)
 for the early detection of uncontrolled symptoms. The ePVA is digital patient-reported
 symptom monitoring system, providing actionable information at point-of-care that enables
 clinicians to provide real-time interventions. The study aims to advance the science of
 cancer care delivery by testing the effectiveness of the ePVA as a digital patient-reported
 monitoring system for patients with HNC in real-world settings and identify implementation
 strategies that optimize the effectiveness of the ePVA in diverse rural and urban settings.
 The study hypothesis is that participants assigned to the ePVA arm will have better
 swallowing, taste and smell, and social function than participants assigned to usual care arm
 at 4 weeks after completing radiation therapy.

ICD-10 Classifications